Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis C Payumo

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Clinical Orthopaedics and Related Research|October 24, 2002
Tissue engineering skeletal muscle for orthopaedic applicationsFrancis C Payumo, Hyun D Kim, Michael A Sherling, et al.
Clinical Pharmacology in Drug Development|January 19, 2018
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCEng-Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Clinical Orthopaedics and Related Research|October 24, 2002
Tissue engineering skeletal muscle for orthopaedic applicationsFrancis C Payumo, Hyun D Kim, Michael A Sherling, et al.
Clinical Pharmacology in Drug Development|January 19, 2018
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCEng-Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, et al.
Pageof 1